全球素食胶囊市场

到 2030 年，全球素食胶囊市场规模将达到 29 亿美元

全球素食胶囊市场规模预计在2024年达到19亿美元，预计在2024-2030年的分析期内将以7.7%的复合年增长率增长，到2030年将达到29亿美元。羟丙基甲基纤维素胶囊是本报告分析的细分市场之一，预计其复合年增长率将达到9.0%，到分析期结束时将达到21亿美元。普鲁兰胶多醣素食胶囊细分市场在分析期间的复合年增长率预计将达到5.0%。

美国市场规模估计为 5.158 亿美元，而中国市场预计复合年增长率为 12.2%

美国素食胶囊市场规模预计在2024年达到5.158亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到6.349亿美元，在2024-2030年的分析期间内，复合年增长率为12.2%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为3.7%和7.4%。在欧洲，德国的复合年增长率预计为5.1%。

全球素食胶囊市场－主要趋势与驱动因素摘要

为什么素食胶囊在健康和保健领域如此受欢迎？

素食胶囊是传统明胶胶囊的植物来源替代品，主要由羟丙基甲基纤维素 (HPMC) 和发酵普鲁兰胶等纤维素聚合物製成。这些胶囊采用非动物性递送方式，符合素食者、纯素、犹太洁食者和清真食品认证者等消费者的道德、文化和饮食偏好。其口感中性、无过敏原特性以及与多种活性成分的兼容性使其适用于膳食补充剂、机能性食品和植物来源配方。随着道德采购和成分透明度成为主流，素食胶囊为产品开发者提供了合规的消费者友善标籤解决方案。

与明胶胶囊不同，素食胶囊不依赖动物源性胶原蛋白，从而消除了疯牛症（BSE）和小儿麻痹病毒（TSE）污染的风险。这一区别在註重健康的市场中尤其重要，因为这些市场对原材料来源和交叉污染风险的审查尤其严格。植物来源胶囊适用于对热和湿度敏感的内容物，这进一步增强了其在洁净标示膳食补充剂中的作用。由于对整体产品设计的需求日益增长，製药公司越来越多地考虑将植物性胶囊用于非处方药。

监管和製造趋势如何支持产品标准化？

合规性和第三方认证已成为素食胶囊在全球市场销售的关键。越来越多的配方製造商寻求获得纯素、清真和犹太洁食认证机构认证的胶囊，以满足出口和标籤要求。这种监管保证在饮食或宗教标准严格的市场中尤其重要。水分含量、保存期限和透氧渗透性等品质标准也已完善，以配合传统明胶胶囊的性能。

製造商正在投资自动化胶囊生产技术，该技术能够处理植物来源薄膜，同时不影响封装速度和准确性。这些升级实现了经济高效的规模化生产，并拓展了其在治疗领域的应用。此外，辅料采购的透明度和可追溯性有助于胶囊供应商满足日益增长的非基因改造、无麸质和无过敏原成分标籤偏好。这些监管和营运方面的改进使素食胶囊在功效和可靠性方面与明胶胶囊相媲美。

哪些创新增强了素食胶囊系统的多功能性？

产品创新的重点是拓展素食胶囊的功能范围，以支持延迟释放、肠溶和缓释性剂型。製造商正在开发能够耐胃酸、在消化道中崩坏并提高特定营养素和活性化合物生物生物有效性的胶囊。耐酸、防潮的胶囊壳对于益生菌和酵素製剂尤其重要，因为这些製剂在到达小肠之前需要受到保护。

组合剂型，例如双重填充和透明包衣胶囊，也正在被引入，以增强视觉吸引力和性能差异化。专为油性、粉末和颗粒填充应用定制的胶囊，使营养补充剂品牌能够在保持素食主张的同时，丰富其产品线。尺寸、颜色和品牌名称的客製化有助于营养补充剂公司将包装美学与品牌形象统一。这些特点对于寻求提升货架展示度和高端定位的直销型营养补充品品牌尤其重要。

哪些市场区隔正在推动全部区域的需求？

素食胶囊市场的成长受到消费者饮食模式、认证要求和产品创新等多种因素的推动。在北美、欧洲和东南亚，对植物来源补充剂和洁净标示配方的需求日益增长，推动了从明胶胶囊转变为植物来源的转变。製药公司也在探索素食胶囊，以涵盖受文化或伦理限制的患者群体。益生菌、草本和功能性补充剂类别的成长，增强了对耐酸和耐湿的素食胶囊的需求。胶囊壳材料的进步，加上製造设备的改进，使得规模化生产变得可行且经济高效。此外，监管机构对更清晰标籤的追求，以及消费者对可追溯、无动物成分的兴趣，迫使契约製造製造商和补充剂品牌优先采用素食胶囊。个人化营养的扩展和对联合用药产品的需求，进一步巩固了素食胶囊在治疗和保健应用领域的市场地位。

部分

产品（羟丙基甲基纤维素胶囊、普鲁兰胶素食胶囊）、功能（即时释功能、缓释功能、延迟释放功能）、用途（抗生素/抗菌用途、维生素/营养保健用途、抗发炎用途、心血管治疗用途、制酸剂/抗发炎用途）、最终用途（药品最终用途、营养保健最终用途、契约製造组织最终用途、化妆品最终用途）

受访公司范例

• ACG（Associated Capsules Pvt Ltd）
• Aenova Group
• AlfaCaps LLC
• Ashland Inc.
• Bright Pharma Caps
• CapsCanada
• Capsugel（Lonza Group）
• Captek Softgel International Inc.
• Catalent Inc.
• Dow Chemical
• Erkang
• EuroCaps
• Lotte Fine Chemical
• Nouryon
• QUALICAPS（Roquette Freres）
• Robinson Pharma Inc.
• Roquette Freres
• Shandong Healsee Capsule Ltd.
• Shin-Etsu Chemical Co., Ltd.
• Sirio Europe GmbH

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Vegetarian Capsules Market to Reach US$2.9 Billion by 2030

The global market for Vegetarian Capsules estimated at US$1.9 Billion in the year 2024, is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2024-2030. Hydroxypropyl Methyl Cellulose Capsules, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the Pullulan Vegetarian Capsules segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$515.8 Million While China is Forecast to Grow at 12.2% CAGR

The Vegetarian Capsules market in the U.S. is estimated at US$515.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$634.9 Million by the year 2030 trailing a CAGR of 12.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 7.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Global Vegetarian Capsules Market - Key Trends & Drivers Summarized

Why Are Vegetarian Capsules Preferred Across Health and Wellness Segments?

Vegetarian capsules are plant-derived alternatives to traditional gelatin capsules and are made primarily from cellulose-based polymers such as hydroxypropyl methylcellulose (HPMC) or fermented pullulan. These capsules provide a non-animal delivery format that meets the ethical, cultural, and dietary preferences of vegetarian, vegan, kosher, and halal consumers. Their neutral taste, absence of allergens, and compatibility with a wide range of active ingredients make them suitable for dietary supplements, functional foods, and botanical-based formulations. As ethical sourcing and ingredient transparency become mainstream, vegetarian capsules offer product developers a compliant solution for consumer-friendly labeling.

Unlike gelatin capsules, vegetarian options do not rely on animal-derived collagen and are thus free from BSE and TSE transmission concerns. This distinction is particularly important in health-conscious markets where ingredient origin and cross-contamination risks are scrutinized. Their suitability for heat-sensitive and moisture-sensitive contents further strengthens their role in clean-label nutraceuticals. Increasingly, pharmaceutical companies are exploring plant-based capsules for over-the-counter medications in response to growing demand for inclusive product design.

How Are Regulatory and Manufacturing Trends Supporting Product Standardization?

Regulatory compliance and third-party certifications have become essential in marketing vegetarian capsules across global markets. Formulators increasingly seek capsules certified by recognized vegan, halal, and kosher authorities to meet export and labeling requirements. This regulatory assurance is especially significant in markets with strict dietary laws or religious standards. Quality standards related to moisture content, shelf life, and oxygen permeability are also being refined to match the performance of traditional gelatin capsules.

Manufacturers are investing in automated capsule production technologies capable of handling plant-based films without compromising on encapsulation speed or accuracy. These upgrades are enabling cost-efficient scale-up and broader application across therapeutic segments. In addition, transparency in excipient sourcing and traceability are helping capsule suppliers address the growing preference for non-GMO, gluten-free, and allergen-free ingredient declarations. These regulatory and operational improvements are helping vegetarian capsules gain parity with gelatin-based systems in both efficacy and reliability.

What Innovations Are Enhancing the Versatility of Vegetarian Capsule Systems?

Product innovation is focused on expanding the functional scope of vegetarian capsules to support delayed-release, enteric-coated, and sustained-release dosage forms. Manufacturers are developing capsules that can withstand stomach acid and disintegrate in targeted sections of the digestive tract, improving the bioavailability of specific nutrients or active compounds. Acid-resistant and moisture-sealed capsule shells are particularly valuable for probiotic and enzyme formulations that require protection until they reach the small intestine.

Combination dosage forms, including dual-fill capsules and transparent-coated variants, are also being introduced to enhance visual appeal and performance differentiation. Capsules tailored for oil-based, powder, and granular fills are allowing supplement brands to diversify product offerings while adhering to vegetarian claims. Customization in size, color, and branding is helping nutraceutical companies align packaging aesthetics with brand identity. These capabilities are particularly important for direct-to-consumer supplement brands seeking to create shelf presence and reinforce premium positioning.

What Market-Specific Factors Are Driving Demand Across Segments and Regions?

Growth in the vegetarian capsules market is driven by several factors linked to consumer dietary patterns, certification requirements, and product innovation. Increasing demand for plant-based supplements and clean-label formulations across North America, Europe, and Southeast Asia is supporting the shift from gelatin to plant-derived capsules. Pharmaceutical companies are also exploring vegetarian capsules for inclusivity in patient demographics with cultural or ethical restrictions. Growth of probiotic, herbal, and functional supplement categories is reinforcing demand for acid-resistant and moisture-tolerant vegetarian capsule formats. Advancements in capsule shell materials, coupled with enhancements in production machinery, are improving scale-up feasibility and cost-efficiency. Additionally, regulatory push for clearer labeling and consumer interest in traceable, animal-free ingredients are compelling both contract manufacturers and supplement brands to prioritize vegetarian capsule adoption. Expansion of personalized nutrition and demand for combination-dose products is further strengthening the market position of vegetarian capsules across therapeutic and wellness applications.

SCOPE OF STUDY:

The report analyzes the Vegetarian Capsules market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Hydroxypropyl Methyl Cellulose Capsules, Pullulan Vegetarian Capsules); Functionality (Immediate-Release Functionality, Sustained-Release Functionality, Delayed-Release Functionality); Application (Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application, Cardiovascular Therapy Application, Antacid & Antiaffluent Application); End-Use (Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use, Cosmetics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• ACG (Associated Capsules Pvt Ltd)
• Aenova Group
• AlfaCaps LLC
• Ashland Inc.
• Bright Pharma Caps
• CapsCanada
• Capsugel (Lonza Group)
• Captek Softgel International Inc.
• Catalent Inc.
• Dow Chemical
• Erkang
• EuroCaps
• Lotte Fine Chemical
• Nouryon
• QUALICAPS (Roquette Freres)
• Robinson Pharma Inc.
• Roquette Freres
• Shandong Healsee Capsule Ltd.
• Shin-Etsu Chemical Co., Ltd.
• Sirio Europe GmbH

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Vegetarian Capsules - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Shift Toward Plant-Based and Ethical Supplement Formats Propels Long-Term Adoption of Vegetarian Capsules
  • Growing Demand for Animal-Free, Gelatin-Free Dosage Forms Drives Market Expansion Across Nutraceutical Applications
  • Increasing Consumer Awareness of Dietary Restrictions Strengthens Demand for Halal, Kosher, and Allergen-Free Capsules
  • Rapid Expansion of Vegan, Ayurvedic, and Herbal Supplement Markets Generates Opportunities for Vegetarian Capsule Manufacturers
  • Rising Scrutiny of Animal-Derived Ingredients and BSE-Related Concerns Accelerate Transition to Vegetarian Capsule Formats
  • Technological Advancements in HPMC and Pullulan Capsule Production Support Heat Stability and Fill Versatility
  • Preference for Clean-Label and Transparent Supplement Solutions Sustains Innovation in Additive-Free Capsule Shells
  • Surge in Preventive Healthcare and Wellness Routines Expands the Addressable Market for Daily Use Vegetarian Capsules
  • Aging Population Need for Gut-Friendly and Digestible Dosage Forms Reinforces Demand for Plant-Based Capsules
  • Expanding E-Commerce and DTC Nutraceutical Channels Increase Visibility and Sales of Certified Vegetarian Capsules
  • High Growth in Sports Nutrition, Cognitive Health, and Immune Support Segments Creates Cross-Sector Demand for Veg Capsules
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Vegetarian Capsules Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Vegetarian Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Vegetarian Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Vegetarian Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Hydroxypropyl Methyl Cellulose Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Hydroxypropyl Methyl Cellulose Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Hydroxypropyl Methyl Cellulose Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Pullulan Vegetarian Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Pullulan Vegetarian Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Pullulan Vegetarian Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Antacid & Antiaffluent Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Antacid & Antiaffluent Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Antacid & Antiaffluent Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Antibiotic & Antibacterial Drugs Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Antibiotic & Antibacterial Drugs Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Antibiotic & Antibacterial Drugs Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Vitamin & Dietary Supplements Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Vitamin & Dietary Supplements Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Vitamin & Dietary Supplements Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Anti-Inflammatory Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Anti-Inflammatory Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Anti-Inflammatory Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Cardiovascular Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Cardiovascular Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Cardiovascular Therapy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Pharmaceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Pharmaceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Pharmaceuticals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Nutraceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Nutraceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Nutraceuticals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Contract Manufacturing Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Contract Manufacturing Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Contract Manufacturing Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Cosmetics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Cosmetics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Cosmetics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Immediate-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Immediate-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Immediate-Release Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Sustained-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Sustained-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Sustained-Release Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Delayed-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Delayed-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: World 16-Year Perspective for Delayed-Release Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: USA 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: USA 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 56: USA Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: USA 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: Canada 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: Canada 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: Canada 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: Canada 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• JAPAN
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: Japan 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: Japan 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: Japan 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: Japan 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• CHINA
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 83: China Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: China 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: China 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: China 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 92: China Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: China 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• EUROPE
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Vegetarian Capsules by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Vegetarian Capsules by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: Europe 16-Year Perspective for Vegetarian Capsules by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Europe 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: Europe 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: Europe 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: Europe 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• FRANCE
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 110: France Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: France 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: France 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 116: France Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: France 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 119: France Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: France Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: France 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• GERMANY
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: Germany 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: Germany 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: Germany 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 131: Germany Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Germany Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Germany 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Italy 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Italy 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Italy 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 143: Italy Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Italy Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Italy 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 146: UK Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: UK 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 149: UK Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: UK 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 152: UK Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: UK 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 155: UK Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: UK Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: UK 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: Spain 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: Spain 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: Spain 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 167: Spain Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Spain Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: Spain 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: Russia 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: Russia 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: Russia 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 179: Russia Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Russia Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: Russia 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Europe 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Vegetarian Capsules by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Vegetarian Capsules by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 16-Year Perspective for Vegetarian Capsules by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Asia-Pacific 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Australia 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Australia 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Australia 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 218: Australia Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Australia Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Australia 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• INDIA
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 221: India Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: India 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 224: India Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: India 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 227: India Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: India 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 230: India Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: India Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: India 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: South Korea 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: South Korea 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: South Korea 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: South Korea Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: South Korea 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Vegetarian Capsules by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Vegetarian Capsules by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Latin America 16-Year Perspective for Vegetarian Capsules by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Latin America 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Latin America 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Latin America 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Latin America Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Latin America 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: Argentina 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: Argentina 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: Argentina 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Argentina Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: Argentina 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: Brazil 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: Brazil 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: Brazil 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Brazil Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: Brazil 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Mexico 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 301: Mexico 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 304: Mexico 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Mexico Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 307: Mexico 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 319: Rest of Latin America 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Vegetarian Capsules by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Vegetarian Capsules by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 322: Middle East 16-Year Perspective for Vegetarian Capsules by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 325: Middle East 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 328: Middle East 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 331: Middle East 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Middle East Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 334: Middle East 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 337: Iran 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 340: Iran 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 343: Iran 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 344: Iran Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Iran Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 346: Iran 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 349: Israel 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 352: Israel 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 355: Israel 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 356: Israel Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Israel Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 358: Israel 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 370: Saudi Arabia 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 373: UAE 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 376: UAE 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 379: UAE 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 380: UAE Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 381: UAE Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 382: UAE 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 394: Rest of Middle East 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• AFRICA
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 397: Africa 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 400: Africa 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 403: Africa 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 404: Africa Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Africa Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 406: Africa 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030

IV. COMPETITION